Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a 12-minute electrical zap ease your numb fingers?

NCT ID NCT07356648

Symptom relief Sponsor: Duzce University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a type of electrical current called diadynamic current can reduce pain and improve hand function in people with carpal tunnel syndrome. About 80 adults with mild to moderate carpal tunnel syndrome will receive this therapy along with standard care like exercises and splints. Researchers will measure changes in symptoms, grip strength, and nerve signals over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinically and electrophysiologically diagnosed with carpal tunnel syndrome (CTS) * Provision of informed consent * Age between 18 and 65 years Exclusion Criteria: * Age below 18 years or above 65 years * Median nerve distal motor latency \> 6.0 ms on nerve conduction studies (NCS) * Thenar muscle atrophy * History of carpal tunnel syndrome surgery * History of steroid injection into the carpal tunnel * History of physical therapy for CTS within the past 6 months * Cervical radiculopathy * Tenosynovitis in the ipsilateral upper extremity * Other compressive neuropathy in the ipsilateral upper extremity * Peripheral polyneuropathy * History of trauma or fracture involving the hand, wrist, or forearm * Pregnancy * Presence of metabolic disease * Inflammatory rheumatic disease * Acute and/or chronic renal failure * Severe cognitive impairment preventing understanding and following simple instructions * Severe visual or hearing impairment preventing participation in treatment * Current use of pregabalin or gabapentin * Systemic diseases (e.g., diabetes mellitus, hypothyroidism, rheumatic diseases)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome (CTS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carpal tunnel syndrome (CTS)

Contacts and locations

Locations

  • Düzce University

    Düzce, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.